Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|1|3|263-275

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.1, Iss.3, 2005-05, pp. : 263-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-based HIV-1 integrase inhibitor design: a future perspective

By Neamati N.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 281-296

Informa Healthcare

Access to resources Recommend Favorite

Structure-Based Inhibitor Design Targeting HIV-1 Integrase

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 3, 2002-09 ,pp. : 217-234

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 5, 2009-07 ,pp. : 337-344

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel BACE1 Inhibitors by Combination of Pharmacophore Modeling, Structure-Based Design and In Vitro Assay

By  

Current Computer - Aided Drug Design, Vol. 12, Iss. 1, 2016-03 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Relationships of HIV-1 Integrase Inhibitors - Enzyme- Ligand Interactions

By  

Current Medicinal Chemistry, Vol. 10, Iss. 18, 2003-09 ,pp. : 1795-1810

Bentham Science Publishers

Access to resources Recommend Favorite